rs2296481
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001256864.2(DNAJC6):c.544-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,612,582 control chromosomes in the GnomAD database, including 32,548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 8482 hom., cov: 32)
Exomes 𝑓: 0.12 ( 24066 hom. )
Consequence
DNAJC6
NM_001256864.2 intron
NM_001256864.2 intron
Scores
2
Splicing: ADA: 0.001528
2
Clinical Significance
Conservation
PhyloP100: 0.341
Genes affected
DNAJC6 (HGNC:15469): (DnaJ heat shock protein family (Hsp40) member C6) DNAJC6 belongs to the evolutionarily conserved DNAJ/HSP40 family of proteins, which regulate molecular chaperone activity by stimulating ATPase activity. DNAJ proteins may have up to 3 distinct domains: a conserved 70-amino acid J domain, usually at the N terminus, a glycine/phenylalanine (G/F)-rich region, and a cysteine-rich domain containing 4 motifs resembling a zinc finger domain (Ohtsuka and Hata, 2000 [PubMed 11147971]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-65379393-C-T is Benign according to our data. Variant chr1-65379393-C-T is described in ClinVar as [Benign]. Clinvar id is 1170298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-65379393-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.593 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC6 | NM_001256864.2 | c.544-9C>T | intron_variant | ENST00000371069.5 | NP_001243793.1 | |||
DNAJC6 | NM_014787.4 | c.373-9C>T | intron_variant | NP_055602.1 | ||||
DNAJC6 | NM_001256865.2 | c.334-9C>T | intron_variant | NP_001243794.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC6 | ENST00000371069.5 | c.544-9C>T | intron_variant | 1 | NM_001256864.2 | ENSP00000360108.4 |
Frequencies
GnomAD3 genomes AF: 0.252 AC: 38236AN: 151866Hom.: 8461 Cov.: 32
GnomAD3 genomes
AF:
AC:
38236
AN:
151866
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.212 AC: 53031AN: 250576Hom.: 9833 AF XY: 0.202 AC XY: 27311AN XY: 135442
GnomAD3 exomes
AF:
AC:
53031
AN:
250576
Hom.:
AF XY:
AC XY:
27311
AN XY:
135442
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.118 AC: 171806AN: 1460598Hom.: 24066 Cov.: 31 AF XY: 0.121 AC XY: 88212AN XY: 726606
GnomAD4 exome
AF:
AC:
171806
AN:
1460598
Hom.:
Cov.:
31
AF XY:
AC XY:
88212
AN XY:
726606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.252 AC: 38314AN: 151984Hom.: 8482 Cov.: 32 AF XY: 0.259 AC XY: 19216AN XY: 74294
GnomAD4 genome
AF:
AC:
38314
AN:
151984
Hom.:
Cov.:
32
AF XY:
AC XY:
19216
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1660
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Juvenile onset Parkinson disease 19A Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 17, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at